M. Javad Aman, PhD
Javad leads IBT and its innovative science programs. He is a distinguished researcher in viral and bacterial diseases with 75+ publications.
Gary Nabors, PhD
Gary heads IBT’s product development team to translate its discovery pipeline into practical solutions for infectious diseases.
Rick Holtsberg, PhD
Rick leads IBT Bioservices’ assay & protein services group and develops IBT’s biochemical reagent portfolio. See Rick’s publications.
Robin Douglas
Robin leads IBT Bioservices with its state-of-the-art infectious disease research capabilities and strong customer service focus.
Rajan Adhikari, PhD
Rajan investigates bacterial pathogens and leads antibacterial vaccine and therapeutic development programs. See Rajan’s publications.
Hatice Karauzum, PhD
Hati investigates bacterial pathogenesis and cellular immune responses. See Hati’s publications.
Agnes Chenine, PhD
Agnes oversees the in vivo studies program for testing new therapies and vaccines in various rodent models. See Agnes’s publications.
Sergey Shulenin, PhD
Thomas Kort
Principal Scientist
Tom works on protein expression and custom scientific projects. See Tom’s publications.
Haimi Shiferaw
Haimi leads IBT Bioservices strategic growth, marketing, and customer management team.
